DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC
Google image searchProduct monograph
Active ingredient
sodium iodide 131 i, 7400 MBq/VIAL
DIN: 02329778
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Description: 74 TO 7400 MBQ/ VIAL
Schedule: Schedule C
Company: JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Date: 14-NOV-2018
ATC:
- V10 — THERAPEUTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V10X — OTHER THERAPEUTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD)
- V10XA — Iodine (131I) compounds (ATC, ATC/DDD)
- V10XA01 — SODIUM IODIDE 131 I (ATC/DDD)
Pharmaceutical standard: USP
